» Articles » PMID: 34771026

Robust Saliva-Based RNA Extraction-Free One-Step Nucleic Acid Amplification Test for Mass SARS-CoV-2 Monitoring

Abstract

Early diagnosis with rapid detection of the virus plays a key role in preventing the spread of infection and in treating patients effectively. In order to address the need for a straightforward detection of SARS-CoV-2 infection and assessment of viral spread, we developed rapid, sensitive, extraction-free one-step reverse transcription-quantitative polymerase chain reaction (RT-qPCR) and reverse transcription loop-mediated isothermal amplification (RT-LAMP) tests for detecting SARS-CoV-2 in saliva. We analyzed over 700 matched pairs of saliva and nasopharyngeal swab (NSB) specimens from asymptomatic and symptomatic individuals. Saliva, as either an oral cavity swab or passive drool, was collected in an RNA stabilization buffer. The stabilized saliva specimens were heat-treated and directly analyzed without RNA extraction. The diagnostic sensitivity of saliva-based RT-qPCR was at least 95% in individuals with subclinical infection and outperformed RT-LAMP, which had at least 70% sensitivity when compared to NSBs analyzed with a clinical RT-qPCR test. The diagnostic sensitivity for passive drool saliva was higher than that of oral cavity swab specimens (95% and 87%, respectively). A rapid, sensitive one-step extraction-free RT-qPCR test for detecting SARS-CoV-2 in passive drool saliva is operationally simple and can be easily implemented using existing testing sites, thus allowing high-throughput, rapid, and repeated testing of large populations. Furthermore, saliva testing is adequate to detect individuals in an asymptomatic screening program and can help improve voluntary screening compliance for those individuals averse to various forms of nasal collections.

Citing Articles

The effect of sample site and collection procedure on identification of SARS-CoV-2 infection.

Davenport C, Arevalo-Rodriguez I, Mateos-Haro M, Berhane S, Dinnes J, Spijker R Cochrane Database Syst Rev. 2024; 12:CD014780.

PMID: 39679851 PMC: 11648846. DOI: 10.1002/14651858.CD014780.


Recent advances in RNA sample preparation techniques for the detection of SARS-CoV-2 in saliva and gargle.

Liu Y, Kumblathan T, Tao J, Xu J, Feng W, Xiao H Trends Analyt Chem. 2023; 165:117107.

PMID: 37317683 PMC: 10204347. DOI: 10.1016/j.trac.2023.117107.


A Systematic Review and Meta-Analysis Comparing the Diagnostic Accuracy Tests of COVID-19.

Vilca-Alosilla J, Candia-Puma M, Coronel-Monje K, Goyzueta-Mamani L, Galdino A, Machado-de-Avila R Diagnostics (Basel). 2023; 13(9).

PMID: 37174941 PMC: 10177430. DOI: 10.3390/diagnostics13091549.


Development and Validation of Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) as a Simple and Rapid Diagnostic Tool for SARS-CoV-2 Detection.

Aldossary A, Tawfik E, Altammami M, Alquait A, Booq R, Sendy B Diagnostics (Basel). 2022; 12(9).

PMID: 36140632 PMC: 9498013. DOI: 10.3390/diagnostics12092232.


Strategies That Facilitate Extraction-Free SARS-CoV-2 Nucleic Acid Amplification Tests.

Delgado-Diaz D, Sakthivel D, Nguyen H, Farrokzhad K, Hopper W, Narh C Viruses. 2022; 14(6).

PMID: 35746782 PMC: 9230587. DOI: 10.3390/v14061311.


References
1.
Kellner M, Ross J, Schnabl J, Dekens M, Matl M, Heinen R . A Rapid, Highly Sensitive and Open-Access SARS-CoV-2 Detection Assay for Laboratory and Home Testing. Front Mol Biosci. 2022; 9:801309. PMC: 9011764. DOI: 10.3389/fmolb.2022.801309. View

2.
Broughton J, Deng X, Yu G, Fasching C, Servellita V, Singh J . CRISPR-Cas12-based detection of SARS-CoV-2. Nat Biotechnol. 2020; 38(7):870-874. PMC: 9107629. DOI: 10.1038/s41587-020-0513-4. View

3.
Guglielmi G . The explosion of new coronavirus tests that could help to end the pandemic. Nature. 2020; 583(7817):506-509. DOI: 10.1038/d41586-020-02140-8. View

4.
Anahtar M, McGrath G, Rabe B, Tanner N, White B, Lennerz J . Clinical Assessment and Validation of a Rapid and Sensitive SARS-CoV-2 Test Using Reverse Transcription Loop-Mediated Isothermal Amplification Without the Need for RNA Extraction. Open Forum Infect Dis. 2021; 8(2):ofaa631. PMC: 7798487. DOI: 10.1093/ofid/ofaa631. View

5.
Assennato S, Ritchie A, Nadala C, Goel N, Tie C, Nadala L . Performance Evaluation of the SAMBA II SARS-CoV-2 Test for Point-of-Care Detection of SARS-CoV-2. J Clin Microbiol. 2020; 59(1). PMC: 7771448. DOI: 10.1128/JCM.01262-20. View